Welcome to this exclusive deep-dive analysis of Kilitch Drugs following their compelling Q3 FY2025 results.
Nice write-up, wld hv been great if more insights were gvn on the management for that's the foundation of an Investment thesis
Thanks for the feedback. We will take a note of it.
Nice write-up, wld hv been great if more insights were gvn on the management for that's the foundation of an Investment thesis
Thanks for the feedback. We will take a note of it.